By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioLineRx Ltd. 

19 Hartum Street
P.O. Box 45158
Jerusalem 91450      Israel
Phone: 972-2-548-9100 Fax: 972-2-548-9101


SEARCH JOBS


Industry
Biotechnology






Company News
BioLineRx Announces Initiation Of Phase Ib/II Trial Of BL-8040 In Pancreatic Cancer Under Immunotherapy Collaboration 7/10/2017 7:01:17 AM
BioLineRx Reports Regulatory Submissions Of Three Phase Ib Trials For BL-8040 In Combination With Atezolizumab For Solid Tumors 6/1/2017 8:00:27 AM
BioLineRx Reports First Quarter 2017 Financial Results 5/25/2017 8:52:31 AM
BioLineRx Announces Regulatory Submission For Phase Ib Trial Of BL-8040 In Combination With Atezolizumab In AML 5/22/2017 10:48:46 AM
BioLineRx To Report First Quarter 2017 Results On May 25, 2017 5/16/2017 12:25:53 PM
BioLineRx To Initiate Phase III Study With BL-8040 As Novel Stem Cell Mobilization Treatment Following Successful Meeting With FDA 5/3/2017 10:03:53 AM
BioLineRx Closes $28.75 Million Underwritten Public Offering Of Its American Depositary Shares 4/5/2017 6:39:44 AM
BioLineRx Prices $25 Million Underwritten Public Offering 3/31/2017 8:54:56 AM
BioLineRx Announces Underwritten Public Offering Of Its American Depositary Shares 3/31/2017 8:44:59 AM
BioLineRx's AGI-134 To Be Presented At AACR 2017 3/27/2017 10:58:12 AM
12345678910...
//-->